Changeflow GovPing Healthcare & Life Sciences Faecalibacterium Longum Patent EP3511406A1, BGI...
Routine Notice Added Final

Faecalibacterium Longum Patent EP3511406A1, BGI Shenzhen, Apr 15, 2026

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office published patent application EP3511406A1 for Faecalibacterium Longum, a bacterial strain with applications in food supplements and pharmaceutical compositions. Applicant BGI Shenzhen seeks protection across 32 designated EU and EEA contracting states including Germany, France, the United Kingdom, Italy, and Spain. The patent covers compositions for metabolic applications including anti-obesity treatments.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 47 changes logged to date.

What changed

EPO published patent application EP3511406A1 for Faecalibacterium Longum, filed by BGI Shenzhen. The application claims bacterial compositions in the C12N classification with applications spanning food supplements and pharmaceutical preparations targeting metabolic conditions.

No compliance obligations arise from this publication for third parties. Competitors developing similar probiotic or microbiome-based products should review the patent claims to assess potential freedom-to-operate concerns before commercial launch in designated contracting states.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

FAECALIBACTERIUM LONGUM AND APPLICATION THEREOF

Publication EP3511406A1 Kind: A1 Apr 15, 2026

Applicants

BGI Shenzhen

Inventors

ZOU, Yuanqiang, XUE, Wenbin, XIAO, Liang, LIU, Chuan

IPC Classifications

C12N 1/20 20060101AFI20200226BHEP A61K 35/741 20150101ALI20200226BHEP A61K 35/74 20150101ALI20200226BHEP A61P 3/08 20060101ALI20200226BHEP A23L 33/135 20160101ALI20200226BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
International
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3511406A1

Who this affects

Applies to
Manufacturers Food manufacturers Pharmaceutical companies
Industry sector
3254.1 Biotechnology
Activity scope
Patent filing IP licensing Biotech research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!